skip to main content
UK Health Security Agency

MDA-MB-361

MDA-MB-361

Catalogue No.

92020423

Cell Line Name

MDA-MB-361

Cell Line Description

This cell line originates from a 40 year old caucasian female suffering from a breast adenocarcinoma but these cells were isolated from a metastatic site in the brain.

General Info

Species

Human

Release Conditions

Restricted - commercial organisations are required to complete the 'Cell Line Release Authorisation for Research Use in Commercial Organisations' release conditions form in the supporting documents section.

Characteristics

Tissue of Origin

Breast (brain metastasis)

Karyotype

Range 54-61 Modal number 56

Disease

Adenocarcinoma

Culture Conditions

Cell Type

Epithelial

Subculture Routine

Split sub-confluent cultures (70-80%) 1:3 to 1:6, i.e. seeding at 3-6x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 37°C. CO₂ is not required.

Culture Medium

L15 + 2mM Glutamine + 15% Foetal Bovine Serum (FBS).

Growth Mode

Adherent

Additional Info

Depositor

The University of Texas M. D. Anderson Cancer Center Office of Technology Commercialization 7515 S. Main, Suite 490, Unit 0510 Houston, Texas 77030

Country of Origin

United States

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

Cailleau R, Young R, Olivé M, Reeves WJ Jr 1974 Breast tumor cell lines from pleural effusions. J Natl Cancer Inst. 53(3):661-74. PMID: 4412247.

Bibliography

Cruciger QV, Pathak S, Cailleau R.1976 Human breast carcinomas: marker chromosomes involving 1q in seven cases. Cytogenet Cell Genet. 17(4):231-5. PMID: 1001030. Cailleau R, Olivé M, Cruciger QV 1978 Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 14(11):911-5.PMID: 730202. Brinkley BR, Beall PT, Wible LJ, Mace ML, Turner DS, Cailleau RM 1980 Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res.;40(9):3118-29.PMID: 7000337. Siciliano MJ, Barker PE, Cailleau R 1979 Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res.39(3):919-22. PMID: 427779. Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL 1994 Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 54(10):2615-21. PMID: 8168088. Faust JB, Meeker TC. 1992 Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res. 52(9):2460-3. PMID: 1568216.

Available Formats

  • Frozen
  • DNA-5µg (100ng/µl)

If use of this culture results in a scientific publication, it should be cited in the publication as: MDA-MB-361 (ECACC 92020423).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.